Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
Link to record
Permanent link

Direct link
Publications (10 of 24) Show all publications
Wikvall, K., Olsson, F., Wåhlén, E., Roy, A., Ubhayasekera, K., Bergquist, J. & Norlin, M. (2026). 24-Hydroxycholesterol suppresses steroid 5α-reductase-catalyzed conversion in human glioblastoma cell lines: A novel link between brain cholesterol homeostasis and androgen metabolism. Neurochemistry International, 193, Article ID 106116.
Open this publication in new window or tab >>24-Hydroxycholesterol suppresses steroid 5α-reductase-catalyzed conversion in human glioblastoma cell lines: A novel link between brain cholesterol homeostasis and androgen metabolism
Show others...
2026 (English)In: Neurochemistry International, ISSN 0197-0186, E-ISSN 1872-9754, Vol. 193, article id 106116Article in journal (Refereed) Published
Abstract [en]

Glioblastoma is the most aggressive primary brain tumor in adults. Androgens are reported to influence the development of glioblastoma. Dihydrotestosterone (DHT) is formed from testosterone by action of the enzyme steroid 5α-reductase and is the most potent growth-inducing androgen metabolite. 24-Hydroxycholesterol, another steroid in the brain, is pivotal for brain cholesterol homeostasis and has been suggested to influence glioblastoma cells. However, a connection between 24-hydroxycholesterol and androgen metabolism related to glioblastoma has not previously been reported. The present study reports that human T98G glioblastoma cells metabolize testosterone into DHT, 3αandrostanediol and androstenedione. The 5α-reductase pathway converted testosterone to DHT and further to 3α-androstanediol. The 17β-hydroxysteroid dehydrogenase pathway metabolized testosterone to androstenedione. Results indicated that the 5α-reductase pathway is the major pathway for testosterone metabolism in this cell line. 24-Hydroxycholesterol significantly suppressed the conversion of testosterone to DHT and 3α-androstanediol, to a similar degree as the synthetic 5α-reductase inhibitor finasteride. Suppression of DHT formation resulted in increased metabolism to androstenedione. Similar effects on DHT formation were observed with the LXR agonist T0901317 as with 24-hydroxycho-lesterol. In addition, 24-hydroxycholesterol suppressed DHT formation in patient-derived primary GB cell lines U3009 and U3013, indicating that the observed connection between 24-hydroxycholesterol and androgen metabolism is not unique for T98G cells. Furthermore, 24-hydroxycholesterol-mediated suppression of DHT formation was also observed in human neuroblastoma SH-SY5Y cells. To summarize, the present data provide information on androgen metabolism in glioblastoma cells and indicate a previously unknown link between cholesterol homeostasis and growth-inducing androgens in glioblastoma and potentially other cell types.

Place, publisher, year, edition, pages
Elsevier, 2026
Keywords
Oxysterol, Cholesterol homeostasis, Androgen metabolism, 5 alpha-reductase, Dihydrotestosterone, Glioblastoma
National Category
Pharmaceutical Sciences
Identifiers
urn:nbn:se:uu:diva-578626 (URN)10.1016/j.neuint.2026.106116 (DOI)001669737600001 ()41506415 (PubMedID)2-s2.0-105027399541 (Scopus ID)
Available from: 2026-02-09 Created: 2026-02-09 Last updated: 2026-02-09Bibliographically approved
Iñiguez-Muñoz, S., Llinàs-Arias, P., Ensenyat-Mendez, M., Bedoya-López, A. F., Solivellas-Pieras, M., Garfias-Arjona, S., . . . Marzese, D. M. (2026). Non-coding somatic single-nucleotide variations affecting glioblastoma-specific enhancer elements regulate tumor-promoting gene networks. Genes and Diseases, 13(1), Article ID 101762.
Open this publication in new window or tab >>Non-coding somatic single-nucleotide variations affecting glioblastoma-specific enhancer elements regulate tumor-promoting gene networks
Show others...
2026 (English)In: Genes and Diseases, ISSN 2352-4820, E-ISSN 2352-3042, Vol. 13, no 1, article id 101762Article in journal, Editorial material (Other academic) Published
Place, publisher, year, edition, pages
Elsevier, 2026
National Category
Cancer and Oncology Medical Genetics and Genomics
Identifiers
urn:nbn:se:uu:diva-579104 (URN)10.1016/j.gendis.2025.101762 (DOI)001577002200001 ()41019514 (PubMedID)2-s2.0-105015827825 (Scopus ID)
Available from: 2026-02-13 Created: 2026-02-13 Last updated: 2026-04-22Bibliographically approved
Rosenbaum, A., Wibom, C., Hammermeister Suger, A., Pensch, R., Roy, A., Brannström, T., . . . Melin, B. (2026). Rare germline variants contribute to glioma predisposition: Whole-genome analysis of a regional cohort of glioma patients. Neuro-Oncology Advances, 8(1), Article ID vdag038.
Open this publication in new window or tab >>Rare germline variants contribute to glioma predisposition: Whole-genome analysis of a regional cohort of glioma patients
Show others...
2026 (English)In: Neuro-Oncology Advances, E-ISSN 2632-2498, Vol. 8, no 1, article id vdag038Article in journal (Refereed) Published
Abstract [en]

Background Gliomas are the most common malignant primary tumor of the central nervous system and show a high mortality, particularly at higher grades. Cancer predisposition syndromes and common low-penetrance single nucleotide polymorphisms have been shown to contribute to glioma risk, but the contribution of rare germline variants remains incompletely understood. Here, we investigated rare germline variants in glioma patients.Methods We performed whole-genome sequencing on 113 glioma patients from Northern Sweden, analyzing rare germline variants across 651 genes. Variants were compared to population controls (ACpop, gnomAD) and validated in TCGA glioma data, a UK Biobank glioma nested case-control study, and a separate cohort of 105 Swedish glioblastomas.Results 17.6% of glioma cases carried a Pathogenic or Likely Pathogenic (P/LP) variant within 1 of the 651 genes, and the number of alleles carrying a P/LP was significantly more than in the reference data (P = 3.2 x 10-3). Many of the observed candidate genes also harbored P/LP variants in our Swedish validation cohort. Overall, gene-based comparison of rare coding variants indicated an enrichment in several genes, including TP53, CREBBP, and DNMT3A.Conclusions Rare P/LP germline variants were more frequent among glioma patients than in the reference population within our predefined gene set. These results suggest a contribution of rare germline variants to glioma risk, particularly in genes involved in DNA repair. While several genes are indicated as enriched with rare variants, only TP53 validates across all 3 patient sets.

Place, publisher, year, edition, pages
Oxford University Press, 2026
Keywords
adult glioma, glioma predisposition, rare variants, whole-genome sequencing
National Category
Cancer and Oncology Medical Genetics and Genomics Neurosciences
Identifiers
urn:nbn:se:uu:diva-583937 (URN)10.1093/noajnl/vdag038 (DOI)001720129100001 ()41878702 (PubMedID)
Funder
Swedish Cancer Society, CAN2018/390Swedish Cancer Society, 232857PjSwedish Cancer Society, 190206PjSwedish Cancer Society, 222223PjSwedish Research Council, 2019-01566Swedish Research Council, 2014-2023 2013-08161Swedish Research Council, 2024-2031 2023-00391Swedish Research Council, 2018-02477Swedish Research Council, 20121-10629Vinnova
Available from: 2026-04-09 Created: 2026-04-09 Last updated: 2026-04-09Bibliographically approved
Wimmer, R., Avalos, C. B., Lestienne, P., Coquand, L., Di Cicco, A., Chehade, C., . . . Baffet, A. D. (2026). Two translocation mechanisms drive neural stem cell dissemination into the human fetal cortex. Neuron, 114(12), 2165-2182
Open this publication in new window or tab >>Two translocation mechanisms drive neural stem cell dissemination into the human fetal cortex
Show others...
2026 (English)In: Neuron, ISSN 0896-6273, E-ISSN 1097-4199, Vol. 114, no 12, p. 2165-2182Article in journal (Refereed) Published
Abstract [en]

The strong increase in the size of the human neocortex is supported by a neural stem cell population, the basal radial glial (bRG) cells. Using live imaging of human fetal tissue and cortical organoids, we identify two translocation mechanisms for bRG cell colonization of the human neocortex. On top of an actomyosin-dependent movement called mitotic somal translocation (MST), we identify a microtubule-dependent motion occurring during interphase that we call interphasic somal translocation (IST). We show that IST is driven by the dynein motor and its activator LIS1, which are recruited to the nuclear envelope by the LINC complex, while MST is controlled by the mitotic cell-rounding pathway. Eighty-five percent of bRG cell trans-location is due to IST, resulting in a total movement of 0.67 mm per month of gestation. Our work identifies how bRG cells colonize the human fetal cortex and further shows that IST and MST also occur in bRG-related glioblastoma cells.

Place, publisher, year, edition, pages
Cell Press, 2026
National Category
Neurosciences
Identifiers
urn:nbn:se:uu:diva-594167 (URN)10.1016/j.neuron.2026.02.002 (DOI)001804938200001 ()41844158 (PubMedID)2-s2.0-105032898987 (Scopus ID)
Available from: 2026-07-13 Created: 2026-07-13 Last updated: 2026-07-13Bibliographically approved
Ruiz-Moreno, C., Salas, S. M., Samuelsson, E., Minaeva, M., Ibarra, I., Grillo, M., . . . Stunnenberg, H. G. (2025). Charting the single-cell and spatial landscape of IDH-wild-type glioblastoma with GBmap. Neuro-Oncology, 27(9), 2281-2295
Open this publication in new window or tab >>Charting the single-cell and spatial landscape of IDH-wild-type glioblastoma with GBmap
Show others...
2025 (English)In: Neuro-Oncology, ISSN 1522-8517, E-ISSN 1523-5866, Vol. 27, no 9, p. 2281-2295Article in journal (Refereed) Published
Abstract [en]

Background Glioblastoma (GB), particularly IDH-wild type, is the most aggressive brain malignancy with a dismal prognosis. Despite advances in molecular profiling, the complexity of its tumor microenvironment and spatial organization remains poorly understood. This study aimed to create a comprehensive single-cell and spatial atlas of GB to unravel its cellular heterogeneity, spatial architecture, and clinical relevance.Methods We integrated single-cell RNA sequencing data from 26 datasets, encompassing over 1.1 million cells from 240 patients, to construct GBmap, a harmonized single-cell atlas. High-resolution spatial transcriptomics was employed to map the spatial organization of GB tissues. We developed the Tumor Structure Score (TSS) to quantify tumor organization and correlated it with patient outcomes.Results We showcase the applications of GBmap for reference mapping, transfer learning, and biological discoveries. GBmap revealed extensive cellular heterogeneity, identifying rare populations such as tumor-associated neutrophils and homeostatic microglia. Spatial analysis uncovered 7 distinct tumor niches, with hypoxia-dependent niches strongly associated with poor prognosis. The TSS demonstrated that highly organized tumors, characterized by well-defined vasculature and hypoxic niches, correlated with worse survival outcomes.Conclusions This study provides a comprehensive resource for understanding glioblastoma heterogeneity and spatial organization. GBmap and the TSS provide an integrative view of tumor architecture in GB, highlighting hypoxia-driven niches that may represent avenues for further investigation. Our resource can facilitate exploratory analyses and hypothesis generation to better understand disease progression.

Place, publisher, year, edition, pages
Oxford University Press, 2025
Keywords
glioblastoma, hypoxia, spatial transcriptomics, single-cell atlas, tumor organization
National Category
Cell and Molecular Biology Cancer and Oncology
Identifiers
urn:nbn:se:uu:diva-578346 (URN)10.1093/neuonc/noaf113 (DOI)001517302400001 ()40312969 (PubMedID)2-s2.0-105018977043 (Scopus ID)
Funder
EU, European Research Council, 101054957Knut and Alice Wallenberg Foundation, KAW 2018.0172Swedish Cancer Society, 2018/604Swedish Research Council, 2019-01238
Available from: 2026-02-06 Created: 2026-02-06 Last updated: 2026-02-06Bibliographically approved
Spyrou, A., Roy, A., Xiong, A., Kundu, S., Lu, X., Jansson, Y., . . . Forsberg-Nilsson, K. (2025). Heparan sulfate N-deacetylase/N-sulfotransferase-1 regulates glioblastoma cell migration and invasion. Matrix Biology, 141, 1-15
Open this publication in new window or tab >>Heparan sulfate N-deacetylase/N-sulfotransferase-1 regulates glioblastoma cell migration and invasion
Show others...
2025 (English)In: Matrix Biology, ISSN 0945-053X, E-ISSN 1569-1802, Vol. 141, p. 1-15Article in journal (Refereed) Published
Abstract [en]

The glioblastoma (GBM) microenvironment undergoes adaptations to support tumor progression, including a dysregulated extracellular matrix, with altered heparan sulfate (HS) proteoglycans. We investigated N-deacetylase/N-sulfotransferase-1 (NDST1) because NDSTs are initial modifying enzymes of HS biosynthesis and have key roles in designing the HS sulfation pattern. This, in turn governs interactions with growth factors and other biomolecules. We report that NDST1 expression is lower in GBM than in the normal brain, and that patient-derived GBM cells, grown under neural stem cell culture conditions have lower levels of HS than normal astrocytes. Overexpression of NDST1 in GBM cells with low inherent NDST1 levels stimulates cell migration, reduce cell adhesion, induce EMT markers and increase invasion. Conversely, when NDST1 levels were reduced by shRNA in GBM cells, that had higher baseline expression, we find that invasion is reduced, and instead, self-renewal capacity increases alongside elevated stem cell marker expression. Moreover, overexpression of NDST1 changes chromatin accessibility of gene regulatory regions with the capacity to affect transcription factor expression, and pathways that favors cell motility and invasion. Furthermore, NDST1 overexpression results in increased activation of several receptor tyrosine kinases. This study shows that low NDST1 levels support GBM cell stemness, whereas high NDST1 levels endow tumor cells with a motile cell phenotype. We therefore propose that NDST1 is important for regulation of the balance between proliferation and invasive properties in GBM cells.

Place, publisher, year, edition, pages
Elsevier, 2025
Keywords
Brain tumor, Glioblastoma, Heparan sulfate, Proteoglycan, Stemness, Tumor invasion
National Category
Basic Cancer Research Cell and Molecular Biology
Identifiers
urn:nbn:se:uu:diva-583215 (URN)10.1016/j.matbio.2025.08.003 (DOI)001694084700001 ()40796061 (PubMedID)2-s2.0-105013481575 (Scopus ID)
Note

De två första författarna delar förstaförfattarskapet

Available from: 2026-03-27 Created: 2026-03-27 Last updated: 2026-03-31Bibliographically approved
Wicher, G., Roy, A., Vaccaro, A., Vemuri, K., Ramachandran, M., Olofsson, T., . . . Forsberg-Nilsson, K. (2025). Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression. Neuro-Oncology Advances, 7(1), Article ID vdaf010.
Open this publication in new window or tab >>Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression
Show others...
2025 (English)In: Neuro-Oncology Advances, E-ISSN 2632-2498, Vol. 7, no 1, article id vdaf010Article in journal (Refereed) Published
Abstract [en]

Background

Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, characterized by aggressive growth and a dismal prognosis. Interleukin-33 (IL-33) and its receptor ST2 have emerged as regulators of glioma growth, but their exact function in tumorigenesis has not been deciphered. Indeed, previous studies on IL-33 in cancer have yielded somewhat opposing results as to whether it is pro- or anti-tumorigenic.

Methods

IL-33 expression was assessed in a GBM tissue microarray and public databases. As in vivo models we used orthotopic xenografts of patient-derived GBM cells, and syngenic models with grafted mouse glioma cells.

Results

We analyzed the role of IL-33 and its receptor ST2 in nonmalignant cells of the glioma microenvironment and found that IL-33 levels are increased in cells surrounding the tumor. Protein complexes of IL-33 and ST2 are mainly found outside of the tumor core. The IL-33-producing cells consist primarily of oligodendrocytes. To determine the function of IL-33 in the tumor microenvironment, we used mice lacking the ST2 receptor. When glioma cells were grafted to ST2-deficient mouse brains, the resulting tumors exhibited a more invasive growth pattern, and are associated with poorer survival, compared to wild-type mice. Tumors in ST2-deficient hosts are more invasive, with increased expression of extracellular matrix remodeling enzymes and enhanced tumor angiogenesis. Furthermore, the absence of ST2 leads to a more immunosuppressive environment.

Conclusions

Our findings reveal that glia-derived IL-33 and its receptor ST2 participate in modulating tumor invasiveness, tumor vasculature, and immunosuppression in glioma.

Place, publisher, year, edition, pages
Oxford University Press, 2025
National Category
Cancer and Oncology
Identifiers
urn:nbn:se:uu:diva-551430 (URN)10.1093/noajnl/vdaf010 (DOI)001416529000001 ()39931535 (PubMedID)2-s2.0-85217904746 (Scopus ID)
Funder
Swedish Research Council, 2021-01629Swedish Cancer Society, 22 2223 PjThe Swedish Brain Foundation, FO2023-0044
Available from: 2025-02-24 Created: 2025-02-24 Last updated: 2025-02-24Bibliographically approved
Iniguez-Munoz, S., Llinas-Arias, P., Ensenyat-Mendez, M., Bedoya-Lopez, A. F., Orozco, J. I. J., Cortes, J., . . . Marzese, D. M. (2024). Hidden secrets of the cancer genome: unlocking the impact of non-coding mutations in gene regulatory elements. Cellular and Molecular Life Sciences (CMLS), 81, Article ID 274.
Open this publication in new window or tab >>Hidden secrets of the cancer genome: unlocking the impact of non-coding mutations in gene regulatory elements
Show others...
2024 (English)In: Cellular and Molecular Life Sciences (CMLS), ISSN 1420-682X, E-ISSN 1420-9071, Vol. 81, article id 274Article, review/survey (Refereed) Published
Abstract [en]

Discoveries in the field of genomics have revealed that non-coding genomic regions are not merely "junk DNA", but rather comprise critical elements involved in gene expression. These gene regulatory elements (GREs) include enhancers, insulators, silencers, and gene promoters. Notably, new evidence shows how mutations within these regions substantially influence gene expression programs, especially in the context of cancer. Advances in high-throughput sequencing technologies have accelerated the identification of somatic and germline single nucleotide mutations in non-coding genomic regions. This review provides an overview of somatic and germline non-coding single nucleotide alterations affecting transcription factor binding sites in GREs, specifically involved in cancer biology. It also summarizes the technologies available for exploring GREs and the challenges associated with studying and characterizing non-coding single nucleotide mutations. Understanding the role of GRE alterations in cancer is essential for improving diagnostic and prognostic capabilities in the precision medicine era, leading to enhanced patient-centered clinical outcomes.

Place, publisher, year, edition, pages
Springer, 2024
Keywords
Enhancers, Promoters, Insulators, Silencers, Single nucleotide polymorphisms, Single nucleotide variants
National Category
Cancer and Oncology Medical Genetics and Genomics
Identifiers
urn:nbn:se:uu:diva-534418 (URN)10.1007/s00018-024-05314-z (DOI)001251324800001 ()38902506 (PubMedID)
Available from: 2024-07-09 Created: 2024-07-09 Last updated: 2025-02-10Bibliographically approved
Cantoni, F., Barbe, L., Roy, A., Wicher, G., Simonsson, S., Forsberg-Nilsson, K. & Tenje, M. (2024). On-chip fabrication of tailored 3D hydrogel scaffolds to model cancer cell invasion and interaction with endothelial cells. APL Bioengineering, 8(4), Article ID 046113.
Open this publication in new window or tab >>On-chip fabrication of tailored 3D hydrogel scaffolds to model cancer cell invasion and interaction with endothelial cells
Show others...
2024 (English)In: APL Bioengineering, E-ISSN 2473-2877, Vol. 8, no 4, article id 046113Article in journal (Refereed) Published
Abstract [en]

The high mortality associated with certain cancers can be attributed to the invasive nature of the tumor cells. Yet, the complexity of studying invasion hinders our understanding of how the tumor spreads. This work presents a microengineered three-dimensional (3D) in vitro model for studying cancer cell invasion and interaction with endothelial cells. The model was generated by printing a biomimetic hydrogel scaffold directly on a chip using 2-photon polymerization that simulates the brain's extracellular matrix. The scaffold's geometry was specifically designed to facilitate the growth of a continuous layer of endothelial cells on one side, while also allowing for the introduction of tumor cells on the other side. This arrangement confines the cells spatially and enables in situ microscopy of the cancer cells as they invade the hydrogel scaffold and interact with the endothelial layer. We examined the impact of 3D printing parameters on the hydrogel's physical properties and used patient derived glioblastoma cells to study their effect on cell invasion. Notably, the tumor cells tended to infiltrate faster when an endothelial cell barrier was present. The potential for adjusting the hydrogel scaffold's properties, coupled with the capability for real-time observation of tumor-endothelial cell interactions, offers a platform for studying tumor invasion and tumor–endothelial cell interactions.

Place, publisher, year, edition, pages
American Institute of Physics (AIP), 2024
National Category
Cell and Molecular Biology
Identifiers
urn:nbn:se:uu:diva-545390 (URN)10.1063/5.0227135 (DOI)001369256200001 ()39634677 (PubMedID)2-s2.0-85211022667 (Scopus ID)
Funder
EU, Horizon 2020, 757444Knut and Alice Wallenberg Foundation, WAF 2016.0112Swedish Research Council, 2019-00207
Available from: 2024-12-19 Created: 2024-12-19 Last updated: 2025-03-13Bibliographically approved
Sullivan, P. F., Meadows, J., Gazal, S., Phan, B. N., Li, X., Genereux, D. P., . . . Lindblad-Toh, K. (2023). Leveraging base-pair mammalian constraint to understand genetic variation and human disease. Science, 380(6643), 367-+, Article ID eabn2937.
Open this publication in new window or tab >>Leveraging base-pair mammalian constraint to understand genetic variation and human disease
Show others...
2023 (English)In: Science, ISSN 0036-8075, E-ISSN 1095-9203, Vol. 380, no 6643, p. 367-+, article id eabn2937Article in journal (Refereed) Published
Abstract [en]

Thousands of genomic regions have been associated with heritable human diseases, but attempts to elucidate biological mechanisms are impeded by an inability to discern which genomic positions are functionally important. Evolutionary constraint is a powerful predictor of function, agnostic to cell type or disease mechanism. Single-base phyloP scores from 240 mammals identified 3.3% of the human genome as significantly constrained and likely functional. We compared phyloP scores to genome annotation, association studies, copy-number variation, clinical genetics findings, and cancer data. Constrained positions are enriched for variants that explain common disease heritability more than other functional annotations. Our results improve variant annotation but also highlight that the regulatory landscape of the human genome still needs to be further explored and linked to disease.

Place, publisher, year, edition, pages
American Association for the Advancement of Science (AAAS), 2023
National Category
Medical Genetics and Genomics Genetics and Genomics
Identifiers
urn:nbn:se:uu:diva-505276 (URN)10.1126/science.abn2937 (DOI)000989260500008 ()37104612 (PubMedID)
Funder
Swedish Research CouncilKnut and Alice Wallenberg FoundationSwedish Cancer SocietySwedish Research Council, D0886501
Available from: 2023-07-31 Created: 2023-07-31 Last updated: 2025-02-10Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0002-3207-6339

Search in DiVA

Show all publications